GENOCEA BIOSCIENCES INC's ticker is GNCA and the CUSIP is 372427104. A total of 70 filers reported holding GENOCEA BIOSCIENCES INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $844,000 | -72.4% | 578,192 | -1.3% | 0.00% | -71.4% |
| Q2 2017 | $3,059,000 | -17.4% | 586,066 | -3.6% | 0.01% | -17.6% |
| Q1 2017 | $3,702,000 | +48.1% | 607,934 | +0.2% | 0.02% | +41.7% |
| Q4 2016 | $2,499,000 | -18.0% | 606,599 | +1.9% | 0.01% | -7.7% |
| Q3 2016 | $3,048,000 | +24.9% | 595,330 | +0.0% | 0.01% | +18.2% |
| Q2 2016 | $2,440,000 | -46.3% | 595,157 | +1.4% | 0.01% | -45.0% |
| Q1 2016 | $4,543,000 | +46.9% | 586,974 | 0.0% | 0.02% | +42.9% |
| Q4 2015 | $3,093,000 | -24.7% | 586,974 | -2.1% | 0.01% | -17.6% |
| Q3 2015 | $4,105,000 | -43.6% | 599,312 | +13.0% | 0.02% | -41.4% |
| Q2 2015 | $7,282,000 | +15.8% | 530,377 | 0.0% | 0.03% | +11.5% |
| Q1 2015 | $6,290,000 | +277.6% | 530,377 | +122.9% | 0.03% | +271.4% |
| Q4 2014 | $1,666,000 | +10.5% | 237,941 | +42.7% | 0.01% | +16.7% |
| Q3 2014 | $1,508,000 | -51.7% | 166,684 | 0.0% | 0.01% | -53.8% |
| Q2 2014 | $3,125,000 | +3.1% | 166,684 | 0.0% | 0.01% | 0.0% |
| Q1 2014 | $3,032,000 | – | 166,684 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 2,055,230 | $24,375,000 | 10.89% |
| Ghost Tree Capital, LLC | 840,000 | $9,962,000 | 1.79% |
| Broadfin Capital, LLC | 1,035,000 | $12,275,000 | 0.96% |
| Redmile Group, LLC | 796,900 | $9,451,000 | 0.85% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 844,257 | $10,013,000 | 0.32% |
| SPHERA FUNDS MANAGEMENT LTD. | 124,200 | $1,473,000 | 0.15% |
| Tourbillon Capital Partners, L.P. | 400,403 | $4,749,000 | 0.12% |
| SABBY MANAGEMENT, LLC | 100,000 | $1,186,000 | 0.05% |
| AXA S.A. | 530,377 | $6,290,000 | 0.03% |
| ARES MANAGEMENT LLC | 31,500 | $377,000 | 0.02% |